+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Diagnostics - Global Market Trajectory & Analytics

  • ID: 338882
  • Report
  • May 2021
  • Region: Global
  • 609 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Acon Laboratories, Inc.
  • B. Braun Melsungen AG
  • Danaher Corporation
  • HemoCue® AB
  • PTS Diagnostics
  • Siemens Healthineers

Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026


Diabetes diagnostics systems are used to measure blood glucose levels or blood sugar levels, which indicates whether or not a person is suffering from diabetes. Demand for diabetes diagnostics devices and systems is being driven by the need for easier, economic, and efficient management of the global diabetes epidemic, improving ease-of-use and accuracy of devices, and development of non-invasive techniques to simplify regular glucose testing. The spread of diabetes at epidemic proportions is driving the requirement for pre-diabetics testing and post-prandial glucose-level monitoring. With increasing levels of patient education on possible ways of preventing and delaying the onset of Type II diabetes, more and more pre-diabetics are expected to start testing blood glucose. Added to this, patients undergoing tests on account of complications arising from undiagnosed condition, such as heart attacks, are likely to spur market potential. Increasing obesity levels globally coupled with growing requirements of aging patients at both facility-based geriatric care as well as home-based managed care facilities is also expected to drive demand for various diabetes diagnostic devices and systems. Technology advancements in diabetes diagnostics that are poised to benefit market prospects in the near term include mHealth Solutions for diabetes diagnosis; wearable glucose testing devices; implantable continuous glucose monitor; and cloud-enabled CGM devices, among others.

Amid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$26.5 Billion in the year 2020, is projected to reach a revised size of US$42.4 Billion by 2026, growing at a CAGR of 8.1% over the analysis period. Test Strips, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$11.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lancets segment is readjusted to a revised 7.5% CAGR for the next 7-year period. Blood glucose test strips are small disposable strips of plastic that enable people with diabetes to measure and monitor their blood sugar levels at home. Each test strip is a laminate of plastic and chemicals that provides a single-use diagnostic test for measuring blood sugar. Persistent growth in the blood glucose test strips market has been driven to a greater extent by an increase in number of diabetics, and also by technological innovations. Blood sugar lancets play a vital role in the early detection of diabetes. The rising prevalence of diabetes, favorable reimbursement policies in developed countries, rising geriatric population, continuous technological advancements, and faster product approvals are some of the key factors spurring demand.

The U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion by 2026


The Diabetes Diagnostics market in the U.S. is estimated at US$10.8 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2026 trailing a CAGR of 9.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR. Growing prevalence of diabetes and other lifestyle and chronic diseases, ageing population, well-established healthcare infrastructure and wider access to care services, higher healthcare awareness among population, and consumer affluence strongly influence the demand for care and diagnostics services in developed countries. Asia-Pacific represents a rapidly expanding market for diabetes diagnostics. Increased convenience, shift towards high-calorie energy-rich foods, and increasingly sedentary lifestyles are contributing to an alarming rise in incidence of diabetes in India and China making the countries the global hub for the disease with the highest number of diabetic adults.

Analog Glucose Monitors Segment to Reach $5.2 Billion by 2026


Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient`s finger or another place on the body. In the global Analog Glucose Monitors segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$579.9 Million by the year 2026, while Latin America will expand at a 7.5% CAGR through the analysis period.

Select Competitors (Total 91 Featured) -

  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care, Inc.
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Beckman Coulter, Inc.
  • HemoCue® AB
  • DexCom, Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co., Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers
  • Sinocare, Inc.
  • PTS Diagnostics
  • Trividia Health, Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech plc
  • Ypsomed AG
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acon Laboratories, Inc.
  • B. Braun Melsungen AG
  • Danaher Corporation
  • HemoCue® AB
  • PTS Diagnostics
  • Siemens Healthineers
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management
  • Diabetes: A Chronic Body Disorder
  • An Introduction to Diabetes Diagnostics
  • Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
  • Developed Regions Lead, Developing Economies to Spearhead Future Growth
  • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
  • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
  • Exhibit 1: World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Exhibit 2: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
  • Exhibit 3: World Diabetes Prevalence (2000-2019)
  • Exhibit 4: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
  • Exhibit 5: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Diabetes Emerges as One of the Leading Causes of Mortality
  • Exhibit 6: Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
  • Competition
  • Exhibit 7: Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019
  • Exhibit 8: Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019
  • Quality Products at Low Prices: Mantra for Success in the Marketplace
  • SMBG Makers Turn to Mobile Devices to Woo Users on the Move
  • World Brands
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
  • Exhibit 9: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Exhibit 10: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
  • Exhibit 11: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
  • Exhibit 12: Diabetes-Related Health Expenditure: Average Spending Per Person (in US$) by Region for 2010 and 2019
  • Increasing Obesity Levels Underpins Market Growth
  • Exhibit 13: Average Per Capita Annual Health Expenditure (In US$) due to Obesity
  • Exhibit 14: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
  • Exhibit 15: Global Continuous Glucose Monitoring Systems Market by Component for 2020E
  • Exhibit 16: Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2020E
  • CGM Demand Benefits from the COVID-19 Pandemic
  • CGM Market Breaks through Barriers to Witness Growing Adoption
  • Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
  • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
  • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
  • Glycated Albumin: A Potential Threat to HbA1c
  • Role of HbA1c Testing in Diabetes Diagnosis and Management
  • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
  • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
  • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
  • Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
  • Blood Sugar Lancets Market: Sustained Growth in Demand
  • Self-Monitoring/Household Blood Glucose Sustains Market Growth
  • Rising Smartphone Penetration Augurs Well for SMBG Market
  • Exhibit 17: Smartphone Penetration Rate as Share of Total Population: 2016-2020
  • Barriers to Adoption of New Technology in BGM Products
  • Accuracy Issues Plague Blood Glucose Meters Market
  • Insulin Pens Rise in Popularity for Administering Insulin
  • Smart Insulin Pens
  • Increasing Role of Self-Injection Devices in Diabetes Management
  • Prefilled Syringe Pen Injectors
  • Human Factors Influence the Design of Self Injection Systems
  • Pain Free Shots: A Growing R&D Domain
  • Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
  • Exhibit 18: Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • Exhibit 19: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
  • Innovations & Product Advancements: Prime Focus Area for Vendors
  • Focus on Development of Wearable Devices
  • An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
  • Companies Develop Innovative Needle-Free Alternatives
  • mHealth Solutions for Diabetes Diagnosis
  • Non-invasive Wearable Glucose Testing Devices
  • Innovations in Insulin Pumps
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES
  • With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
  • Exhibit 20: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
  • Exhibit 21: Diabetes Prevalence by Ethnicity: 2019
  • Aging Demographics: A Factor Driving Diabetes Prevalence
  • Exhibit 22: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
  • Exhibit 23: North American Aging Population (in Thousands) by Age Group: 1975-2050
  • Exhibit 24: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019
  • Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
  • Regulatory Guidance for Glucose Meter Companies
  • Insulin Syringes Dominate the Insulin Delivery Devices Market
  • Emerging Grey Market for Testing Strips
  • Competition
  • Companies Focus on Research for Better Diabetes Diagnostics
CANADA
  • Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
  • Exhibit 34: Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
JAPAN
  • Aging Population Drives Diabetes Diagnostics Market
  • Exhibit 25: Diabetes Statistics in Japan (2019): Number of Adults with Diabetes (in ‘000s), Adults with Undiagnosed Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in ‘000s)
CHINA
  • Increasing Diabetes Incidence Drives Market Growth
  • Exhibit 26: Diabetes Statistics in China for 2019
  • Lower Penetration Offers High Growth Potential
  • Exhibit 27: Chinese Glucose Meters Breakdown of Revenues by Leading Companies for 2019
EUROPE
  • Diabetes Diagnostics Market in Europe: A Promising Outlook
  • Exhibit 28: Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
  • Exhibit 29: Diabetes Statistics in Europe (2019): Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries
  • Reimbursement Scenario
FRANCE

GERMANY

ITALY

UNITED KINGDOM
  • Market Overview
  • Diabetic Foot Ulcers in UK
SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC
  • Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
  • Exhibit 30: Diabetes and Population Statistics in South East Asia (2019 & 2045)
  • Exhibit 31: Diabetes and Population Statistics in Western Pacific (2019 & 2045)
  • Exhibit 32: Diabetes Statistics in Select Asia-Pacific Countries: Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for 2019
  • Public and Private Sector Diabetes Care
AUSTRALIA

INDIA
  • Expanding Diabetic Population Spurs Growth in the Indian Market
  • Blood Glucose Monitoring Market: An Overview
  • HbA1c Testing Continues to Gain Momentum
  • Glucose Meters Rely on Imported Technology
SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA
  • Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
  • Exhibit 33: Diabetes and Population Statistics in South & Central America (2019 & 2045)
ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 91
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care, Inc.
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Beckman Coulter, Inc.
  • HemoCue® AB
  • DexCom, Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co., Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers
  • Sinocare, Inc.
  • PTS Diagnostics
  • Trividia Health, Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech plc
  • Ypsomed AG
Note: Product cover images may vary from those shown
Adroll
adroll